Format

Send to

Choose Destination
Support Care Cancer. 2019 Jul;27(7):2361-2370. doi: 10.1007/s00520-019-04722-3. Epub 2019 Mar 27.

Prophylactic and therapeutic effects of honey on radiochemotherapy-induced mucositis: a meta-analysis of randomized controlled trials.

Liu TM1, Luo YW1, Tam KW2,3,4,5,6, Lin CC7,8,9, Huang TW10,11.

Author information

1
School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
2
Center for Evidence-Based Health Care, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
3
Department of Medical Research, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
4
Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
5
Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
6
Cochrane Taiwan, Taipei Medical University, Taipei, Taiwan.
7
School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan.
8
School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
9
Alice Ho Miu Ling Nethersole Charity Foundation, Tai Po, Hong Kong.
10
Cochrane Taiwan, Taipei Medical University, Taipei, Taiwan. tsaiwei@tmu.edu.tw.
11
School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan. tsaiwei@tmu.edu.tw.

Abstract

PURPOSE:

Oral mucositis is a common side effect of radiochemotherapy and may adversely affect the patients' quality of life (QoL). Honey application may reduce the mucositis grade in patients. Here, we conducted a meta-analysis of randomized controlled trials (RCTs) to evaluate the prophylactic and therapeutic effects of honey on radiochemotherapy-induced oral mucositis.

METHODS:

Publications on RCTs were extracted from the PubMed, Embase, CINAHL, and Cochrane Library databases. The primary outcomes were mucositis grades and pain scores. Secondary outcomes were the recovery time and QoL. The study was registered with PROSPERO (number CRD42018108486).

RESULTS:

Nineteen RCTs, involving 1276 patients, were reviewed. Honey considerably mitigated oral mucositis in both prophylactic and therapeutic phases. In the prophylactic phase, intolerable mucositis development was significantly prevented in the honey-treated group (RR = 0.18, 95% confidence interval [CI] = 0.09 to 0.41). Patients treated with honey showed significant decrease in pain scores in the first month of treatment (weighted mean difference [WMD] = - 3.25, 95% CI = - 4.41 to - 2.09) and at the end of the treatment (WMD = - 2.32, 95% CI = - 4.47 to - 0.18).

CONCLUSION:

Honey, which is relatively cheap and easily available, prevented mucositis and effectively mitigate mucositis in patients after radiochemotherapy. Moreover, it significantly reduced the mucositis grade and engendered a fast and painless healing process. Therefore, honey use during and after radiochemotherapy is recommended for mucositis prevention and treatment.

KEYWORDS:

Chemotherapy; Honey; Meta-analysis; Mucositis; Radiotherapy

PMID:
30919153
DOI:
10.1007/s00520-019-04722-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center